Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-12-26
2006-12-26
Ketter, James (Department: 1636)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S024310
Reexamination Certificate
active
07153657
ABSTRACT:
Methods are provided for detecting a cell proliferative disorder associated with TSLC1 by contacting a proliferating cell of a subject suspected of having the disorder with a reagent that detects TSLC1 and detecting the level of TSLC1 in the proliferating cell. TSLC1 is a single gene whose expression is reduced or absent in A549 and some other NSCLC, hepatocellular carcinoma and pancreatic cancer cell lines. It has further been discovered that TSLC1 expression or suppression is perfectly correlated with promoter methylation state. Restoration of TSLC1 expression to normal or higher levels is sufficient by itself to suppress tumor formation. The invention further provides methods of treating such disorders by contacting cells of a patient suffering from the disorder with a therapeutically effective amount of a reagent that modulates TSLC1 level in the proliferating cells.
REFERENCES:
patent: 5552277 (1996-09-01), Nelson et al.
patent: 5786146 (1998-07-01), Herman et al.
patent: 5856094 (1999-01-01), Sidransky et al.
patent: 6017704 (2000-01-01), Herman et al.
patent: 6200756 (2001-03-01), Herman et al.
patent: 6251594 (2001-06-01), Gonzalgo et al.
patent: 6265171 (2001-07-01), Herman et al.
patent: 6596493 (2003-07-01), Reeves et al.
Murakami et al. PNAS, vol. 95, 1998, pp. 8153-8158.
Gomyo et al., “A 2-mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of Chromosome 11q23.2”,Genomics,Database Gencore Accession No. AB017563, (2) 139-146, 1999.
Kuramochi et al., “TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer”,Nature Genetics, vol. 27, 427-430, Apr. 2001.
Fukuhara et al., “Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrance proteins”,Oncogene, vol. 20, 5401-5407, 2001.
Murakami Yoshinori
Reeves Roger Harper
DLA Piper Rudnick Gray Cary US LLP
Ketter James
National Cancer Center Research Institute
The Johns Hopkins University School of Medicine
LandOfFree
Diagnosis and treatment of tumor-suppressor associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis and treatment of tumor-suppressor associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and treatment of tumor-suppressor associated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3675818